首页> 外国专利> Vìrus respiratory syncytial (RSV) human group B, isolated, recombinantemente generated, attenuated vaccine, a process to immunize a indivìduo to induce protection against RSV subgroup B,The compositio

Vìrus respiratory syncytial (RSV) human group B, isolated, recombinantemente generated, attenuated vaccine, a process to immunize a indivìduo to induce protection against RSV subgroup B,The compositio

机译:乙型呼吸道合胞(RSV)人B组,分离,重组产生的减毒疫苗,免疫个体以诱导针对RSV亚组B的保护的方法,减毒并分离出产生传染性RSV B组的组成,方法核酸分子。

摘要

"Vu00ecrus respiratory syncytial (RSV) human group B, isolated, recombinantemente generated, attenuated vaccine, a process to immunize a indivu00ecduo to induce protection against RSV subgroup B,The composition, process for producing infectious RSV subgroup B attenuated, and isolated nucleic acid molecule are described sinciciais respiratory virus attenuated recombinantemente generated.Isolates of subgroup B, having at least a mutation in the gene atenuadora RNA polymerase. They are formulated vaccines comprising such virus and a physiologically acceptable vehicle.The vaccines are used to immunize an individual to induce protection against respiratory viruses sinciciais.
机译:乙型呼吸道合胞(RSV)人类B组,分离的重组产生的减毒疫苗,一种免疫个体的方法,以诱导针对RSV B亚组的保护,该组合物,生产传染性RSV B亚组的方法减毒, B亚群中至少有atenuadora RNA聚合酶基因的突变,它们是由这种病毒和一种生理学上可接受的载体配制而成的疫苗。一个人,以诱导对呼吸道中华绒毛病毒的防护。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号